About
Oxford Heartbeat is a UK-based medical technology company founded in 2015, headquartered in London. The company specializes in developing AI-powered surgical planning software aimed at enhancing the safety and accuracy of high-risk brain stenting procedures. Their core product, PreSize® Neurovascular, is a CE-marked technology that allows clinicians to plan and rehearse brain stenting surgeries in a virtual environment. This software helps surgeons simulate different stent sizes and types, enabling them to select the optimal device for each patient and reducing risks associated with the procedures. The technology is co-designed with clinicians to address their pre-operative needs and has been validated for high accuracy in device deployment simulation. Oxford Heartbeat is actively involved in clinical impact trials and has received recognition for its innovation, including a Purple Plaque for the Innovate UK Women in Innovation Award in 2024. The company has secured significant funding from various sources, including a £1.5 million grant from Innovate UK, and has strong ties to UCL and NHS hospitals, enhancing its mission to improve patient outcomes in neurovascular interventions.
Technologies
Keywords
Company Information
- Employees15
- Total Funding$2083182
Location
103c Camley Street, London, England, United Kingdom, N1C 4
